MedTrace Logo

Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance

NCT02969200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2018-10-16

No results posted yet for this study

Summary

The aim of this study was to investigate renal function decline by measured glomerular filtration rate (mGFR) in patients with FD during enzyme replacement therapy, and to explore the influence of age on renal function in FD.

Conditions

Interventions

DRUG

Enzyme replacement therapy

All patients included in the study have received enzyme replacement therapy with either agalsidase alfa and/or agalsidase beta

Sponsors & Collaborators

  • Ulla Feldt-Rasmussen

    lead OTHER

Principal Investigators

  • Ulla V Feldt-Rasmussen, MD, DMSc · Department of Medical Endocrinology, Copenhagen University Hospital, Rigshospitalet

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-09-30
Completion
2016-12-09

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02969200 on ClinicalTrials.gov